Sneddon IB.Cerebrovascular lesions and livedo reticularis. Br J Dermatol. 1965;77:180-185.
2.
Lossos A, Ben-Hur T, Ben-Nariah Z, et al: Familial Sneddon’s syndrome. J Neurol. 1995;242:164-168.
3.
Scott IA, Boyle RS.Sneddon’s syndrome. Aust NZ J Med. 1986;16:799-802.
4.
Lousa M, Sastre JL, Cancelas JA, et al.Study of antiphospholipid antibodies in a patient with Sneddon’s syndrome and her family. Stroke. 1994;25(5): 1071-1074.
5.
Fetoni F, Berti E, Cecca E, et al.Sneddon’s syndrome: clinical and immunohistochemical findings. Clin Neurol Neurosurg. 1994;96:310-313.
6.
Frances C, Papo T, Wechsler B, et al.Sneddon syndrome with or without antiphospholipid antibodies: a comparative study in 46 patients. Medicine. 1999;78:209-219.
7.
Ehrmann S.Ein neues Gefabeta symptom bei Lues. Wien Med Wochenschr. 1907;57:777-782.
8.
Zelger B, Sepp N, Stockhammer G, et al.Sneddon’s syndrome. Arch Dermatol. 1993;129:437-447.
9.
Sepp N, Zelger B, Schuler G, et al.Sneddon’s syndrome—an inflammatory disorder of small arteries followed by smooth muscle proliferation. Am J Surg Pathol. 1995;19:448-453.
10.
Zelger B, Sepp N, Schmid KW, et al.Life history of cutaneous vascular lesions in Sneddon’s syndrome. Hum Pathol. 1992;23:668-675.
11.
Stockhammer GJ, Felber SR, Aichner FT, et al.Sneddon’s syndrome and antiphospholipid antibodies: clarification of a controversy by skin biopsy? Stroke. 1992;23:1182-1183.
12.
Gambetti P, Lugaresi E, van Bogaert L.Sur une forme particuliere de la maladie de Winiwarter-Buerger cerebrale. Acta Neurol Psychiatr Belg. 1966;66:535-552.
13.
Pette AD, Wasserman BA, Adams NL, et al.Familial Sneddon’s syndrome: clinical, hematologic, and radiographic findings in two brothers. Neurology. 1994;44:399-405.
14.
Levine SR, Langer SL, Albers JW, et al.Sneddon’s syndrome: an antiphospholipid antibody syndrome? Neurology. 1988;38:798-800.
15.
Kalashnikova LA, Nasonov EL, Kushekbaeva AE, et al.Anticardiolipin antibodies in Sneddon’s syndrome. Neurology. 1990;40:464-467.
16.
Rebollo M, Val JF, Garijo F, et al.Livedo reticularis and cerebrovascular lesions (Sneddon’s syndrome): clinical, radiological, and pathological features in eight cases. Brain. 1983;106: 965-979.
17.
Gruppo RA, DeGrauw TJ, Palasis S, et al.Strokes, cutis marmorata telangiectatica congenita, and factor V Leiden. Pediatr Neurol. 1998;18(4):342-345.
18.
Punt J.Surgical management of paediatric stroke. Pediatr Radiol. 2004; 34:16-23.
19.
Kim T, Eun B.Moyamoya disease in a child with previous acute necrotizing encephalopathy. Pediatr Radiol. 2003;33:644-647.
20.
Kalashnikova LA, Nasonov EL, Borisenko VV, et al.Sneddon’s syndrome: cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol. 1991;9:357-361.
21.
Antoine JC, Michel D, Garnier P, et al.Rheumatic heart disease and Sneddon’s syndrome. Stroke. 1994;25:689691-689691.
22.
Tourbah A, Piette JC, Iba-Zizen MT, et al.The natural course of cerebral lesions in Sneddon syndrome. Arch Neurol. 1997;54:53-60.
23.
Weissenborn K, Lubach D, Schwabe C, et al.Sneddon’s syndrome: clinical course and outcome. J Neurol. 1989;236:34-37.
24.
Baxter P, Gardner-Medwin D, Green SH, et al.Congenital livedo reticularis and recurrent stroke-like episodes. Dev Med Child Neurol. 1993;35:917-926.
